Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-13-001823
Filing Date
2013-09-17
Accepted
2013-09-17 10:09:34
Documents
10
Period of Report
2013-07-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT form10q.htm 10-Q 512844
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 11022
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 10960
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 7183
  Complete submission text file 0001493152-13-001823.txt   5280394

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cgnh-20130731.xml EX-101.INS 410727
6 XBRL SCHEMA FILE cgnh-20130731.xsd EX-101.SCH 40863
7 XBRL CALCULATION FILE cgnh-20130731_cal.xml EX-101.CAL 66923
8 XBRL DEFINITION FILE cgnh-20130731_def.xml EX-101.DEF 99734
9 XBRL LABEL FILE cgnh-20130731_lab.xml EX-101.LAB 258882
10 XBRL PRESENTATION FILE cgnh-20130731_pre.xml EX-101.PRE 204892
Mailing Address 6295 NORTHAM DRIVE, UNIT 8 MISSISSAUGA, A6 L4V 1W8
Business Address 6865 SW 18TH STREET SUITE B13 BACA RATON FL 33433 905.673.8501
CardioGenics Holdings Inc. (Filer) CIK: 0001089029 (see all company filings)

EIN.: 880380456 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28761 | Film No.: 131100201
SIC: 7389 Services-Business Services, NEC